Short course of radiation therapy effective for treatment of
A study at UCLA, Los Angeles concluded that higher doses of stereotactic body radiotherapy (SBRT) over a significantly shorter period of time has the same successful outcome as from longer course of treatment in men with low- or intermediate-risk prostate cancer.

The research team, directed by lead author Dr. Amar Kishan, Assistant professor of Radiation oncology at UCLA and researcher at the UCLA Jonsson Comprehensive Cancer Center submitted their findings with positive outcomes.

The study was conducted on 2142 men with low-risk, intermediate-risk and favourable intermediate-risk of prostate cancer; treated with SBRT between the years 2000 - 2012 in order to determine the clinical efficacy of radiational therapy for shorter periods.

The key conclusive points from the study are:

- The 7-year incidence of biochemical recurrence for low-risk is 4.5%, for intermediate disease risk: 8.6% and 14.9% for favourable intermediate-risk disease

- Data represent the majority of the men followed are free of prostate cancer seven years after treatment

- Doesn't offers any additional toxicity on a higher dose exposure

Read the complete article here: